SRTA · XBRL financial data

Strata Critical Medical financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (SRTA's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue from contracts with customers47,478*51,51467,94574,87754,357*54,30670,80149,29866,787*67,38472,50674,081
Cost of revenue38,468*41,37551,59155,04041,768*42,32853,06437,68455,117*53,26757,29157,261
Gross profit————year only7,0539,00710,654—14,11715,21516,820
Selling, general and administrative————year only12,33013,29215,91219,341*15,60513,99615,140
General and administrative41,242*17,20925,13620,41218,954*17,31420,14216,301————
Total operating expenses(7,841)*———year only12,73813,64816,27620,817*17,09120,62320,651
Operating income (loss)(35,633)*(9,868)(12,149)(3,537)(8,372)*(7,583)(4,954)(5,622)(6,405)*(2,974)(5,408)(3,831)
Other income (expense)669*———————————
Income tax expense (benefit)(1,023)*(84)52(118)(105)*(17)2100*000
Net income (loss)(33,941)*(4,234)(11,326)(1,954)(9,793)*(3,493)(3,743)57,416(8,833)*2,154(10,516)(7,615)
Earnings per share, basic USD per share(0.45)*(0.06)(0.15)(0.03)(0.12)*(0.04)(0.05)0.70(0.10)*0.03(0.12)(0.09)
Earnings per share, diluted USD per share—(0.06)(0.15)(0.03)(0.12)*(0.04)(0.05)0.70(0.10)*0.03(0.12)(0.09)
Weighted average shares, basic thousands of shares74,760*75,79677,60478,04478,536*79,89281,29782,45584,669*85,32386,21488,274
Weighted average shares, diluted thousands of shares67,892*75,79677,60478,04478,536*79,89281,29782,45584,669*90,16986,21488,274

Balance sheet

CSV

Fiscal quarters (SRTA's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents27,87336,75826,30820,02818,37834,83058,75422,75330,96858,72316,31735,136
Marketable securities138,264114,215115,643116,310108,75785,17654,66653,16530,263666,4366,505
Accounts receivable21,00523,55027,72324,48121,59122,12828,17237,53839,95839,60243,40742,772
Prepaid and other current assets17,97118,18311,1809,56310,7479,32013,3248,76324,73925,49054,58640,461
Total current assets206,261194,008182,912171,760160,742152,312156,480122,482126,192124,145121,010125,139
Property and equipment, net2,8993,46822,09330,55030,91832,56833,69738,56136,44440,08740,70439,622
Right-of-use asset23,48424,57621,12322,8138,8768,6508,4533,2743,1074,1953,9403,287
Goodwill40,37339,77739,57442,95241,05042,03844,25184,60788,21088,589106,946101,918
Total assets294,938282,792280,331282,945256,675250,550257,919335,078325,472327,618332,698328,884
Total current liabilities35,49123,24530,28627,18122,72621,88126,31227,87419,79420,94245,77945,118
Lease liability, non-current19,73821,10117,86419,2716,0185,7065,3182,8172,6553,4813,2012,765
Total liabilities60,63846,18350,94549,44634,73730,81834,81952,07846,40041,88753,38052,509
Accumulated deficit(159,754)(163,988)(175,151)(177,105)(186,898)(190,391)(194,134)(136,718)(145,551)(143,397)(153,913)(161,528)
Total stockholders' equity234,300236,609229,386233,499221,938219,732223,100283,000279,072285,731279,318276,375
Total liabilities and equity294,938282,792280,331282,945256,675250,550257,919335,078325,472327,618332,698328,884
Common shares outstanding (cover page) thousands of shares75,43377,34677,93478,31479,69481,01781,69686,36786,98986,52788,46789,320

Cash flows

CSV

Fiscal quarters (SRTA's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)(33,941)*(4,234)(11,326)(1,954)(9,793)*(3,493)(3,743)57,416(8,833)*2,154(10,516)(7,615)
Stock-based compensation3,153*4,3185,647*5,402*4,526*4,2175,349*1,680*6,586*5,0353,706*5,049*
Depreciation and amortization1,806*1,5941,5591,2791,530*1,6971,7761,704*3,008*3,0608,515*7,312*
Net cash from operating activities(9,320)*(15,551)8,429*6,355*(1,752)*(246)(3,064)*(37,297)*(8,307)*3,8855,687*9,458*
Purchases of property and equipment24*81616,163*9,313*4,583*2,6192,299*2,829*1,848*5,1792,490*400*
Net cash from investing activities75*24,562(16,908)*(12,646)*3,976*20,40728,680*2,398*18,265*24,729(43,881)*13,461*
Share repurchases0*——0*0*——0*0*———
Net cash from financing activities(23)*54(1,208)*(731)*(3,874)*(4,246)(1,137)*(1,787)*(1,742)*(859)(4,212)*(4,099)*
Net change in cash(9,253)*9,039(9,694)*(6,960)*(1,759)*16,04124,630*(37,302)*8,216*27,755(42,406)*18,820*

Compare with peers

SIC 8000 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 8000 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Strata Critical Medical35,13674,0819,458*89.3M— 10-QSep 30, 2026
Talkspace39,15961,67211,385*165.8M— 10-QJun 30, 2026
DocGo25,23373,425(9,242)*98.9M2.7 quarters 10-QJun 30, 2026
InnovAge Holding119,253264,75728,742136.5M— 10-QSep 30, 2026
U S Physical Therapy24,887214,05934,370*14.9M— 10-QJun 30, 2026
LifeStance Health Group225,943435,35499,912*382.1M— 10-QJun 30, 2026
Pennant Group15,273297,98421,830*34.9M— 10-QJun 30, 2026
Omada Health221,71287,8354,007*61.2M— 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.